Patient Access Medicines

Introduction

Oddway International facilitates patient access medicines through a regulated named patient supply framework. This service supports individual patient medicine supply when required treatments are unavailable, discontinued, or restricted in a patient’s local market.

We operate strictly as a pharmaceutical wholesaler and exporter, enabling case-based medicine access under applicable international regulations.
Oddway International does not operate as a retail pharmacy and does not sell medicines online.

What Are Patient Access Medicines?

It refer to treatments supplied for a specific, identified patient under a recognised named patient medicine supply or special access medicines pathway.

This framework is commonly used when:

• A medicine is not marketed or temporarily unavailable locally
• A patient requires a specific formulation or strength
• Standard therapeutic alternatives are unsuitable
• Continuity of treatment is medically necessary

Each request is handled as an individual patient medicine supply, not as a commercial retail transaction.

Scope of Patient Access Programs

Through established patient access programs, Oddway International may assist with sourcing:

• Specialty and high-value medicines
• Oncology and rare disease treatments
• Anti-infective and antiviral medicines
• Chronic and life-saving therapies
• Discontinued or hard-to-source products

All patient access medicines are supplied only after documentation review and are subject to export feasibility and regulatory permissions.

Regulatory & Compliance Framework

All patient access medicines are managed through a case-based medicine supply process, aligned with international pharmaceutical trade norms.

Key principles include:

• Supply against a valid medical prescription
• Identification of a named individual patient
• Case-specific documentation review
• Regulated export and international medicine shipping
• No bulk consumer supply or repeat retail sales

Oddway International does not:

• Display medicine prices
• Accept online orders or payments
• Operate shopping carts or ecommerce systems
• Promote medicines for self-medication

How the Patient Access Process Works

1. Patient Access Request
   A patient, caregiver, or healthcare professional submits a request with prescription details.
2. Case Review
   Regulatory feasibility and sourcing availability are evaluated on a named patient supply basis.
3. Approval Assessment
   Each case is reviewed individually; acceptance is not automatic.
4. Regulated Dispatch
   If approved, medicines are supplied strictly for the identified patient only.

This structured process ensures traceability, accountability, and compliance.

Important Information for Patients & Caregivers

• Oddway International is not a pharmacy
• We do not provide general consumer medicine sales
• Patient access medicines are supplied only under special access or named patient frameworks
• Final acceptance depends on regulatory, medical, and logistical criteria

Where appropriate, patients may be advised to coordinate with licensed healthcare providers or local importers in their country.

Why Choose Oddway International for Patient Access Medicines?

• Experience in international patient access medicines sourcing
• Structured, compliance-first approach
• Case-based handling (not mass retail)
• Support for complex and hard-to-source therapies
• Clear separation between wholesale supply and patient access facilitation

Patient Access Medicines in the United Kingdom (UK)

In the United Kingdom, patient access medicines are commonly managed under named patient supply and special access pathways used by hospitals and clinicians when treatments are unavailable through standard channels.

Requests typically arise when:

• A medicine is not marketed in the UK
• A specific formulation or strength is required
• Continuity of treatment is medically necessary

All UK-related patient access requests are handled strictly on a case-by-case basis, supported by valid prescriptions and clinical documentation, and supplied under applicable export and import regulations.

Patient Access Medicines in the European Union (EU)

Across the European Union, patient access medicines are frequently associated with named patient medicine supply and special access medicines programs, particularly for specialty, oncology, and rare disease therapies.

EU patient access requests often involve:

• Cross-border medicine access
• Temporary supply for identified patients
• Treatments approved in one jurisdiction but unavailable in another

Oddway International supports individual patient medicine supply only where regulatory feasibility permits, ensuring documentation review and compliant international dispatch.

Patient Access Medicines in the United Arab Emirates (UAE)

In the UAE, patient access medicines are commonly required for patients seeking treatments that are not readily available through local supply channels.

Typical scenarios include:

• Specialty or high-value medicines
• Medicines required for treatment continuity
• Patient-specific therapy needs

Requests related to the UAE are assessed under a special access medicines and named patient supply framework, with strict adherence to documentation, prescription validation, and regulated international medicine shipping procedures.

Patient Access Medicines Across Africa

Across multiple African countries, patient access medicines play an important role in addressing availability gaps for essential and specialty therapies.

Patient access requests from Africa often involve:

• Individual patient medicine supply for life-saving treatments
• Cross-border sourcing for unavailable medicines
• Case-based access supported by hospitals, NGOs, or caregivers

All Africa-related requests are reviewed individually and handled as patient-specific medicine supply, not as commercial retail distribution.

Internal Resources & Related Services

Patient access medicines supplied under a named patient medicine supply framework often require coordination with regulated pharmaceutical trade and logistics processes. To understand how these services are structured, you may also review the following resources:

• Our pharmaceutical export services support compliant international sourcing and case-based medicine supply for authorised requests.
• Our pharmaceutical wholesale services outline how medicines are supplied to licensed institutions, hospitals, and regulated entities worldwide.
• Our international medicine shipping capabilities explain how patient-specific medicines are dispatched under applicable export and import regulations.

These services operate independently from patient access facilitation and reflect Oddway International’s role as a B2B pharmaceutical wholesaler and exporter.